Message #6 From:
NewsBot Date: July 28, 2006 05:00:00 AM
CHNG News China Natural Gas to Report Second Quarter 2006 Financial Results on August 3, 2006
NEW YORK--(BUSINESS WIRE)--July 28, 2006--China Natural Gas Inc. (OTCBB:CHNG, website: www.naturalgaschina.com) announced today that it will report its financial results for the second quarter ended June 30, 2006 on Thursday, August 3, 2006 before the U.S. markets open.
The management team will host its first earnings conference call on the same day at 8:30 am Eastern Time (Beijing/Hong Kong Time: 8:30 pm, August 3, 2006). Chairman and Chief Executive Officer Charles Qinan Ji and Chief Financial Officer Xiaogang Zhu will be on the call to discuss the quarterly results and highlights, and answer questions.
Interested parties may participate in the conference call by dialing 800-218-0713 (international: 303-262-2138), 10-15 minutes prior to the initiation of the call. A replay of the call will be available by dialing 800-405-2236 (international 303-590-3000), and entering passcode 11067467#. The replay will be available through August 17, 2006.
The conference call will be available on webcast live and available for replay at the company's corporate web site at www.naturalgaschina.com for 90 days.
China Natural Gas, Inc., ("CHNG"), a Delaware company, is the first China based US public natural gas services provider that owns and operates a 120 kilometer long compressed natural gas pipeline in China's Xi'An area, a fast growing Chinese city supported by a population of 7 million and is the "gateway" to the broad Western regions of China. CHNG has three profitable business segments: end user delivery of natural gas services to residential, commercial and industrial customers; wholesale natural gas to retail natural gas filling stations; and retail natural gas at company-owned natural gas filling stations. The city of Xi'An has approximately 20,000 Taxis, 3,000 buses and 2,000 special purpose vehicles that are powered by compressed natural gas. Approximately 8.6% of the company's shares are owned by Bodisen Biotech, Inc. (AMEX: BBC)
